Ozempic, the miracle weight loss drug made a buzz in the celebrity camp, but before you jump in queue, check out the latest research on drug side effects. Is Ozempic really worth its weight (loss)?
Since 2022, many celebrities have jumped on the Ozempic and Wegovy bandwagon for weight loss, boosting the popularity of these drugs beyond their original purpose of managing type 2 diabetes. According to a research conducted on US veterans, the drugs offer benefits like reduced risk of heart attacks, lower substance abuse rates, and decreased likelihood of Alzheimer’s disease, their rapid weight-loss effects have raised concerns. Users report side effects such as severe joint pain, digestive issues, fainting, disturbed sleep patterns, and potential muscle and tissue loss. Despite their effectiveness, further research is needed to understand their long-term impacts, and their use should be approached with caution. (BBC Global News Podcast via Spotify)
What Is Ozempic ?
Ozempic, a brand name for the drug Semaglutide, is a revolutionary medication initially developed to treat Type 2 diabetes. Approved by the FDA in 2017, it belongs to a class of drugs known as GLP-1 receptor agonists (Glucagon-like Peptide-1), which work by mimicking the body’s natural hormones to regulate blood sugar levels. Beyond its diabetes-related benefits, Ozempic has become a widely recognized tool for weight loss, even gaining popularity among non-diabetics.
Administered as a ‘once-weekly injection’ via pens, Ozempic suppresses appetite, slows digestion, and enhances the body’s insulin response. These effects not only help in glycemic control but also promote significant weight loss. Its use has expanded under the higher-dose formulation branded as Wegovy, specifically approved for managing obesity.
Despite its proven medical benefits, Ozempic has sparked widespread debate due to its off-label use for quick weight loss, especially among celebrities and influencers. While many hail it as a miracle drug, healthcare professionals caution that it should only be used under medical supervision to avoid risks such as gastrointestinal side effects and other potential complications. With its dual role in managing diabetes and addressing obesity, Ozempic has cemented itself as a transformative therapy, though its rising demand has raised accessibility and ethical concerns for those who need it most.
Medical Benefits (Other Than For Diabetes)
Blood Pressure:
Ozempic has demonstrated the ability to lower blood pressure in patients, particularly those with type 2 diabetes and obesity. In clinical trials, individuals using semaglutide experienced a modest reduction in both systolic (top number) and diastolic (bottom number) blood pressure. The blood pressure-lowering effects of Ozempic are likely a result of its weight loss benefits and its role in improving insulin sensitivity, which leads to better metabolic control. By reducing the body’s need for high insulin levels, Ozempic helps reduce vascular resistance, supporting a more normalized blood pressure. These improvements are important for patients with hypertension or those at risk of cardiovascular diseases.
Cholesterol:
Ozempic is effective in improving lipid profiles, which is vital for managing cardiovascular health, especially in people with type 2 diabetes or obesity. Clinical studies show that semaglutide lowers LDL cholesterol (the “bad” cholesterol) and triglycerides, both of which are key contributors to heart disease. Additionally, there is a modest increase in HDL cholesterol (the “good” cholesterol), which helps remove excess cholesterol from the bloodstream. These improvements in cholesterol levels are largely due to the weight loss and enhanced metabolic control facilitated by Ozempic. As a result, it helps reduce the overall cardiac risk, making it an important tool for preventing heart-related issues.
Weight Loss:
Ozempic’s ability to promote weight loss is one of its most significant effects, especially for individuals struggling with obesity or type 2 diabetes. The drug works by suppressing appetite, increasing feelings of fullness, and slowing gastric emptying, which leads to reduced calorie intake. Clinical studies have shown that patients using Ozempic can lose 10-15% of their body weight over several months, with some patients losing even more. This weight loss not only improves insulin sensitivity but also reduces the risk of heart disease, stroke, and other obesity-related complications. As weight loss is often challenging for individuals with these conditions, Ozempic offers a valuable option for achieving sustained weight management.
Celebrity Usage and Public Discourse
The effectiveness of ozempic or Wegovy in weight management has attracted attention from various public figures:
Oprah Winfrey:
In a recent episode of The Oprah Podcast, Oprah Winfrey shared her experience with GLP-1 weight-loss medications like Ozempic, revealing how it changed her understanding of weight management. She acknowledged that her previous beliefs about willpower and weight loss were misguided, recognizing that many people, especially those who are thin, do not struggle with constant hunger. Oprah discussed how societal stigma around obesity and her own past struggles with weight loss led her to rethink the notion of obesity as a disease rather than an issue of willpower. Her comments sparked some controversy, with critics arguing that they oversimplify the complexities of weight management.
Kathy Bates:
Kathy Bates has discussed her weight loss journey, which included a combination of lifestyle changes and medical help. After being diagnosed with type 2 diabetes in 2017, Bates lost 80 pounds through healthier eating and regular exercise. To shed the final 20 pounds, she turned to Ozempic, a medication known to suppress appetite and aid weight loss. However, Bates clarified that her transformation was not solely due to the drug, emphasizing that it was a combination of hard work and medical support. Her openness about using Ozempic sparked debate on social media, with some critics questioning her decision.
Elon Musk:
Elon Musk has openly discussed using weight-loss medications like Ozempic, sharing on social media that he lost weight with the drug and even referred to himself as “Ozempic Santa” in a festive post. Musk has expressed support for making GLP-1 inhibitors more accessible, believing they could improve Americans’ health and quality of life. His stance contrasts with Robert F. Kennedy Jr.’s opposition to the widespread use of such drugs, advocating for lifestyle changes instead. Musk’s openness has sparked public discussion about the ethics and accessibility of Ozempic and similar medications.
Medical Concerns
Gastrointestinal Issues:
The most common side effects of Ozempic are gastrointestinal in nature, including nausea, vomiting, diarrhea, and stomach pain. These symptoms are often temporary but can be severe for some patients, leading to discontinuation of the medication. The discomfort tends to subside as the body adjusts to the drug, but individuals should monitor their symptoms and consult their healthcare provider if the side effects persist or worsen.
Pancreatitis and Thyroid Tumors:
Ozempic carries a risk of pancreatitis (inflammation of the pancreas), which can lead to severe abdominal pain, nausea, and vomiting. Though rare, this condition requires immediate medical attention. Additionally, there is a potential risk for thyroid tumors, including medullary thyroid cancer, as seen in animal studies, leading to a black box warning from the FDA. Patients with a family history of thyroid cancer or pancreatitis should approach the medication with caution.
Kidney Function and Hypoglycemia Risks:
In some cases, Ozempic may impact kidney function, especially in individuals with pre-existing kidney conditions. Monitoring kidney health is crucial, and discontinuation may be necessary if renal problems arise. Additionally, when combined with other diabetes medications like insulin, Ozempic can increase the risk of hypoglycemia (low blood sugar), leading to symptoms such as dizziness, confusion, and sweating.
The adoption of ozempic and such other drugs by celebrities and public figures has sparked discussions about its role in weight management and the ethical considerations of its use for cosmetic purposes. Healthcare professionals emphasize the importance of using such medications under medical supervision, considering potential side effects and the necessity of addressing underlying health conditions.
In summary, semaglutide serves as a multifaceted medication with applications in diabetes management, weight loss, and cardiovascular health. Its prominence in public discourse underscores the need for informed and supervised use, especially when adopted for non-medical reasons.
Sources: UCLA Health, The Independent, The Health Site, Ozempic, Manchester Evening News, FDA
Comments 1